Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation.

Tokunaga F, Nishimasu H, Ishitani R, Goto E, Noguchi T, Mio K, Kamei K, Ma A, Iwai K, Nureki O.

EMBO J. 2012 Oct 3;31(19):3856-70. doi: 10.1038/emboj.2012.241. Epub 2012 Aug 28.

2.

A20-mediated negative regulation of canonical NF-κB signaling pathway.

Pujari R, Hunte R, Khan WN, Shembade N.

Immunol Res. 2013 Dec;57(1-3):166-71. doi: 10.1007/s12026-013-8463-2. Review.

PMID:
24242761
3.

Regulation of NF-κB signaling by the A20 deubiquitinase.

Shembade N, Harhaj EW.

Cell Mol Immunol. 2012 Mar;9(2):123-30. doi: 10.1038/cmi.2011.59. Epub 2012 Feb 20. Review.

4.

Linear ubiquitination-mediated NF-κB regulation and its related disorders.

Tokunaga F.

J Biochem. 2013 Oct;154(4):313-23. doi: 10.1093/jb/mvt079. Epub 2013 Aug 21. Review.

PMID:
23969028
5.

ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling.

Verstrepen L, Carpentier I, Verhelst K, Beyaert R.

Biochem Pharmacol. 2009 Jul 15;78(2):105-14. doi: 10.1016/j.bcp.2009.02.009. Epub 2009 Feb 27. Review.

PMID:
19464428
6.

Expression, biological activities and mechanisms of action of A20 (TNFAIP3).

Verstrepen L, Verhelst K, van Loo G, Carpentier I, Ley SC, Beyaert R.

Biochem Pharmacol. 2010 Dec 15;80(12):2009-20. doi: 10.1016/j.bcp.2010.06.044. Epub 2010 Jul 3. Review.

PMID:
20599425
7.
8.

The zinc finger domain of IKKγ (NEMO) protein in health and disease.

Shifera AS.

J Cell Mol Med. 2010 Oct;14(10):2404-14. doi: 10.1111/j.1582-4934.2010.01054.x. Review.

9.

Deubiquitinases in the regulation of NF-κB signaling.

Harhaj EW, Dixit VM.

Cell Res. 2011 Jan;21(1):22-39. doi: 10.1038/cr.2010.166. Epub 2010 Nov 30. Review.

10.

The biology of A20-like molecules.

Enesa K, Evans P.

Adv Exp Med Biol. 2014;809:33-48. Review.

PMID:
25302364
11.

CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.

Sun SC.

Cell Death Differ. 2010 Jan;17(1):25-34. doi: 10.1038/cdd.2009.43. Review.

12.

A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions.

Heyninck K, Beyaert R.

Trends Biochem Sci. 2005 Jan;30(1):1-4. Review.

PMID:
15653317
13.

A20: linking a complex regulator of ubiquitylation to immunity and human disease.

Ma A, Malynn BA.

Nat Rev Immunol. 2012 Nov;12(11):774-85. doi: 10.1038/nri3313. Epub 2012 Oct 12. Review.

14.

A20: from ubiquitin editing to tumour suppression.

Hymowitz SG, Wertz IE.

Nat Rev Cancer. 2010 May;10(5):332-41. doi: 10.1038/nrc2775. Epub 2010 Apr 12. Review.

PMID:
20383180
15.

Regulation of NF-κB by deubiquitinases.

Harhaj EW, Dixit VM.

Immunol Rev. 2012 Mar;246(1):107-24. doi: 10.1111/j.1600-065X.2012.01100.x. Review.

16.

The biology of A20-binding inhibitors of NF-kappaB activation (ABINs).

Verstrepen L, Carpentier I, Beyaert R.

Adv Exp Med Biol. 2014;809:13-31. Review.

PMID:
25302363
17.

Linear ubiquitination signals in adaptive immune responses.

Ikeda F.

Immunol Rev. 2015 Jul;266(1):222-36. doi: 10.1111/imr.12300. Review.

18.

Cystic Fibrosis from Laboratory to Bedside: The Role of A20 in NF-κB-Mediated Inflammation.

Bannon A, Zhang SD, Schock BC, Ennis M.

Med Princ Pract. 2015;24(4):301-10. doi: 10.1159/000381423. Epub 2015 Apr 25. Review.

19.

A20 expressing tumors and anticancer drug resistance.

da Silva CG, Minussi DC, Ferran C, Bredel M.

Adv Exp Med Biol. 2014;809:65-81. Review.

PMID:
25302366
20.

A20 in inflammation and autoimmunity.

Catrysse L, Vereecke L, Beyaert R, van Loo G.

Trends Immunol. 2014 Jan;35(1):22-31. doi: 10.1016/j.it.2013.10.005. Epub 2013 Nov 15. Review.

PMID:
24246475

Supplemental Content

Support Center